Skip to content
Screener

Fate Therapeutics FATE Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$1.3MMiss by $192.9K
EPS-$0.26Beat by $0.03
Revenue estimate$1.5M
EPS estimate-$0.29

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.27

FAQ

When did Fate Therapeutics report Q1 2026 earnings?
Fate Therapeutics (FATE) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Fate Therapeutics's Q1 2026 revenue and EPS?
Fate Therapeutics reported revenue of $1.3M and eps of $-0.26 for Q1 2026.
Did Fate Therapeutics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.5M by $192.9K. EPS beat the consensus estimate of $-0.29 by $0.03.
How did Fate Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 20.3% from $1.6M a year earlier and eps grew 18.8% from $-0.32.
Where can I find Fate Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-220691) and the 10-Q periodic report (0001193125-26-220696) directly on SEC EDGAR. The filing index links above go to sec.gov.